These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113 [TBL] [Abstract][Full Text] [Related]
3. LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation. Marras C; Klein C; Lang AE; Wakutani Y; Moreno D; Sato C; Yip E; Munhoz RP; Lohmann K; Djarmati A; Bi A; Rogaeva E Neurobiol Aging; 2010 Apr; 31(4):721-2. PubMed ID: 18644660 [TBL] [Abstract][Full Text] [Related]
4. Lrrk2 R1441 substitution and progressive supranuclear palsy. Ross OA; Whittle AJ; Cobb SA; Hulihan MM; Lincoln SJ; Toft M; Farrer MJ; Dickson DW Neuropathol Appl Neurobiol; 2006 Feb; 32(1):23-5. PubMed ID: 16409550 [TBL] [Abstract][Full Text] [Related]
6. LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Spanaki C; Latsoudis H; Plaitakis A Neurology; 2006 Oct; 67(8):1518-9. PubMed ID: 17060595 [No Abstract] [Full Text] [Related]
7. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909 [TBL] [Abstract][Full Text] [Related]
8. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. González-Fernández MC; Lezcano E; Ross OA; Gómez-Esteban JC; Gómez-Busto F; Velasco F; Alvarez-Alvarez M; Rodríguez-Martínez MB; Ciordia R; Zarranz JJ; Farrer MJ; Mata IF; de Pancorbo MM Parkinsonism Relat Disord; 2007 Dec; 13(8):509-15. PubMed ID: 17540608 [TBL] [Abstract][Full Text] [Related]
9. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
10. Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration. Gaig C; Ezquerra M; Martí MJ; Valldeoriola F; Muñoz E; Lladó A; Rey MJ; Cardozo A; Molinuevo JL; Tolosa E J Neurol Sci; 2008 Jul; 270(1-2):94-8. PubMed ID: 18353371 [TBL] [Abstract][Full Text] [Related]
11. Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany. Madzar D; Schulte C; Gasser T Eur J Neurol; 2009 Nov; 16(11):1230-2. PubMed ID: 19538213 [TBL] [Abstract][Full Text] [Related]
12. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Skipper L; Shen H; Chua E; Bonnard C; Kolatkar P; Tan LC; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yuen Y; Farrer M; Liu JJ; Tan EK Neurology; 2005 Oct; 65(8):1319-21. PubMed ID: 16247070 [TBL] [Abstract][Full Text] [Related]
13. LRRK2: both a cause and a risk factor for Parkinson disease? Foroud T Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895 [No Abstract] [Full Text] [Related]